Zepp Health (ZEPP) Q2 2025 Earnings Call August 03, 2025 09:30 PM ET Company ParticipantsGrace Zhang - Investor RelationsWayne Wang Huang - CEOLeon Cheng Deng - CFOSiddharth Rajeev - VP & head - researchDylan Chu - Portfolio ManagerConference Call ParticipantsNone - AnalystOperatorHello, ladies and gentlemen. Thank you for standing by for ZEP Health Corporation's Second Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in listen only mode. Today's conference call is bei ...

Financial Data and Key Metrics Changes - ZEP Health Corporation achieved a remarkable 46% year-over-year increase in revenue, reaching $59.4 million, marking the first quarter of year-over-year revenue growth since 2021 [7][21] - Gross margin for Q2 2025 was 36.2%, consistent with Q1 2025 but slightly down year-over-year due to a higher proportion of lower-margin entry-level products [22] - Adjusted operating loss narrowed to $4.9 million, an improvement of 42% compared to the previous year [27] Business Line Data and Key Metrics Changes - The Amazfit brand was the sole contributor to revenue growth, with strong demand for the T Rex series and the introduction of new products like Balance two and Helios Chef [7][21] - The Balance two smartwatch targets multi-sport athletes and integrates advanced tracking features, contributing to the premiumization strategy [9][10] - The entry-level B6 and Active two series continued to see steady growth across major global markets, supported by retail and Amazon partnerships [11][12] Market Data and Key Metrics Changes - In the U.S., Amazfit ranked as the second most improved wearable brand year-over-year, with significant sales growth in the EMEA region, particularly in Germany, Italy, and France [20] - Prime Day sales surged by approximately 60% compared to the previous year, showcasing the effectiveness of marketing strategies [15] Company Strategy and Development Direction - The company is focused on a strategic transformation towards premium high-impact products, differentiating itself in the competitive wearable technology market [16] - ZEP Health is expanding its premium product portfolio and enhancing brand recognition through partnerships with athletes and targeted marketing campaigns [14][15] - The operational strategy includes a flexible supply chain and diversified manufacturing to mitigate tariff impacts and enhance competitiveness [13][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued growth and value revaluation as the market recognizes the company's efforts [32][33] - The outlook for Q3 2025 anticipates revenue in the range of $72 million to $76 million, representing 70% to 79% year-over-year growth [29] - Management expects gross margins to improve in the second half of the year due to a favorable product mix and new product launches [38][51] Other Important Information - The company has cumulatively retired $8 million of debt since 2023, optimizing its capital structure [28] - Research and development expenses increased by 4.2% year-over-year to $10.3 million, reflecting investments in new technologies [24] Q&A Session Summary Question: What are the drivers behind the recent spike in share price? - Management noted strong product reception and brand recognition, along with a value discovery journey in the market [32] Question: How many more product launches are expected in the second half of the year? - Management indicated that there will be exciting products in the pipeline for Q3 and Q4, matching or exceeding previous launches [35] Question: What gross margin can be expected for the full year? - Management expects gross margins to expand in the second half of the year, potentially reaching closer to 40% [37][38] Question: What percentage of imports to the U.S. comes from Vietnam, and what are the current tariffs? - Tariffs for products shipped from China to the U.S. are just below 25%, while those from Vietnam are close to zero due to tariff waivers [40] Question: What sales contribution is expected from the new Helios strap launch? - The Helios strap has received positive customer feedback and carries a healthy gross margin, with expectations for strong sales [48][51]

Financial Data and Key Metrics Changes - The company reported a 10% year-over-year growth in Amazfit revenue, marking the first growth after two years of transformation [6] - Gross margin for Q1 2025 was 37.3%, higher than both Q4 2024 and Q1 2024, despite a negative impact from tariffs [28][29] - Operating expenses for Q1 totaled $31.5 million, an increase from $29.3 million in Q4 2024 and $27.8 million in Q1 2024 [30] Business Line Data and Key Metrics Changes - Amazfit branded products achieved a 10.2% year-over-year growth, reflecting strong market reception for new models Active2 and BIP6 [27] - The initial sales momentum of Active2 and BIP6 surpassed previous versions, securing top positions in major markets [12][15] Market Data and Key Metrics Changes - The U.S. market accounts for approximately 15% of the company's revenue, with tariffs currently having minimal impact on operations [9] - In Italy, the company's market share for no SIM smartwatch units reached 23.3%, ranking second in the core wearable smartwatch market [13] Company Strategy and Development Direction - The company is focusing on diversifying its supply chain and optimizing cost management to mitigate risks from geopolitical complexities [6][26] - Plans to strengthen presence in entry-level markets and deepen collaboration with offline channel partners are in place [22] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about achieving year-over-year growth in overall sales for the first time since 2021, driven by product innovation and partnerships [22][56] - The company remains vigilant regarding macroeconomic challenges but expects operational efficiencies to offset tariff impacts [37] Other Important Information - The company successfully refinanced a significant portion of its short-term debt into long-term instruments, improving liquidity [35] - The anticipated tariff impact for 2025 is estimated to be around $2 million to $3 million, which is expected to be offset by operational efficiency gains [37] Q&A Session Summary Question: Impact of tariffs on U.S. exports produced in Vietnam - The company expects a full-year tariff impact of $2 million to $3 million, which will be offset by global operating efficiency gains [40][41] Question: Market pricing strategies - The company is monitoring competitors and will adjust pricing strategies on a case-by-case basis, but does not plan to be the first mover [47] Question: Operating expenses reduction timeline - A significant reduction in operating expenses is expected in Q2, as Q1 expenses were influenced by product launch events [48] Question: New product launches for the year - The company aims to refresh all major product lines throughout the year, with multiple new product launches planned [50][54]

Zepp Health (ZEPP) Q4 2024 Earnings Call March 26, 2025 07:00 PM ET Company Participants Grace Yujia Zhang - Director of Investor RelationsWang Huang - Founder, Chairman & CEOLeon Cheng Deng - Chief Financial OfficerSiddharth Rajeev - Head of ResearchYan Yeung - Chief Operating OfficerNicolas Britten-Jones - Managing Director Conference Call Participants None - Analyst Grace Yujia Zhang And other risks and uncertainties are included in the company's annual report on Form 20 F for the fiscal year ended 12/31 ...

Financial Data and Key Metrics Changes - Overall sales in Q4 2024 rose by more than 40% quarter over quarter, aligning with guidance despite macroeconomic headwinds and supply bottlenecks [3][21] - Gross margin for 2024 reached 39%, up from 26.2% in 2023, indicating significant margin expansion [4][23] - Cash on hand at the end of 2024 was $112 million, providing ample runway for market investments [4][30] - Adjusted operating loss for Q4 2024 was $7.4 million, the narrowest in the past four quarters, demonstrating sequential improvement [27][28] - GAAP net loss for Q4 2024 was $36.9 million, including various impairments and deferred tax asset valuation allowances [28] Business Line Data and Key Metrics Changes - The successful launch of the T Rex3 smartwatch significantly boosted sales and market demand, establishing a strong position in the outdoor and sports smartwatch segment [5][21] - The Amazfit Active2 and BIP6 series are expected to drive further sales growth in the entry-level segment [7][11] - The T Rex series has outperformed competitors, achieving higher profitability and steady growth [11][12] Market Data and Key Metrics Changes - Global smartwatch sales fell by 7% in 2024, primarily due to a decline in Apple Watch shipments, which dropped by 19% [18][19] - Sales in China grew from 19% to 25% of the market, marking a significant shift in market dynamics [19] - The Indian market saw a decline from 30% to 23% due to issues with ultra-cheap devices [19] Company Strategy and Development Direction - The company is transitioning towards a brand-empowered, high-margin business model, focusing on technological innovation and global marketing [3][4] - A comprehensive smart wearable ecosystem is being built, integrating advanced AI-driven health solutions and performance tracking [14][15] - The strategy includes launching one to two new products every quarter in 2025, aiming for a different demand pattern compared to 2024 [22][61] Management's Comments on Operating Environment and Future Outlook - Management remains optimistic about growth in 2025, driven by new product launches and a focus on AI features [20][45] - The company is confident in its long-term growth trajectory, supported by a robust product pipeline and strategic partnerships [15][30] - Despite challenges in 2024, the company effectively managed costs and is positioned for sustained growth [32] Other Important Information - The company is committed to maintaining a lean operating structure while investing in R&D and marketing [25][27] - A share repurchase program will continue in 2025, reflecting confidence in the company's long-term value [15][31] Q&A Session Summary Question: Impact of new tariffs on Chinese smartwatch imports - Management indicated minimal impact due to proactive supply chain management and dual sourcing strategies [17][35] Question: Details on impairment losses and tax increases - Impairment losses were due to investments in upstream and downstream technology companies that underperformed [38][41] Question: Shift in demand towards lower-priced players - Management noted that while the market declined, segments like outdoor and sports smartwatches, particularly the T Rex series, are performing well [43][45] Question: Long-term strategy and vision for a global health ecosystem - The company is diversifying its product portfolio and exploring B2B opportunities while focusing on consumer health solutions [49][52] Question: Relationship with Xiaomi and its impact - The relationship remains strong, but the company is focusing on self-branded products to achieve profitability before expanding revenue with Xiaomi [55][59] Question: Stock liquidity and market valuation - Management acknowledged the stock's illiquidity and emphasized ongoing buyback programs and strategic growth initiatives to enhance market perception [63][65] Question: New product roadmap for 2025 - The company plans to launch multiple new products across different price segments, which is expected to drive significant growth in 2025 [70][73]